Clinical Trials on Candidaemia

Total 62 results

AM-Pharma

Withdrawn

A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Proven Candidaemia (SLIC)

Candidaemia

Netherlands
Taipei Medical University WanFang Hospital

Completed

Study and Analysis of Micafungin for Non-albican Candidemia: Efficacy, Risk Factor and Clinical Manifestation

Non-albicans Candidemia

Taiwan
Taipei Medical University WanFang Hospital

Unknown

The Relationship Between Morphology and Virulent Genes of Candida Albicans and Clinical Aspects, Surveillance of Fungemia

Candidemia Prognostic Factor and Mycobiological Analysis.

Taiwan
Fujian Shengdi Pharmaceutical Co., Ltd.

Not yet recruiting

A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis

Patients With Candidemia and/or Invasive Candidiasis
Centre Hospitalier Universitaire Dijon

Unknown

Study of Innate Host Immune Response to C. Glabrata Clinical Isolates Resistant to Echinocandins: Impact on the Management of Candidemia in High-risk Patients (CAHOHR)

Candidemia of C. Glabrata

France
Karolinska University Hospital

Completed

Value of PCT When Diagnosing Candidemia

The Value of Procalcitonin in Patients With Suspected Candidemia

Sweden
Radboud University Medical Center
Horizon 2020 - European Commission

Recruiting

Safety and Efficacy of Interferon-Gamma 1b in Patients With Candidemia

Candidemia

Netherlands, United States, Switzerland, Germany, Romania, Greece
Pfizer

Completed

A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.

Candidiasis
Assistance Publique - Hôpitaux de Paris

Unknown

Dosage of Plasma 1, 3-β-D-glucan for the Diagnosis of Candidemia. (BDG-REA)

Infection, Fungal

France
Universidade Federal do Rio de Janeiro

Completed

Negative Beta Glucan in ICU Patients

Candidemia

Brazil
T2 Biosystems

Completed

Serial Therapeutic and Antifungal Monitoring Protocol (STAMP)

Candidemia

United States
Society of Indian Human & Animal Mycologist

Completed

SIHAM Candidemia Network:An Observational Study

Candidemia

India
T2 Biosystems

Completed

Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT) (DIRECT)

Candidemia

United States
Fundacion SEIMC-GESIDA
Merck Sharp & Dohme LLC; Pfizer; Gilead Sciences; Astellas Pharma Inc

Completed

Prospective Population Study on Candidemia in Spain (CANDIPOP)

Fungemia

Spain
Pfizer

Completed

A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects

Candidemia | Aspergillosis

United States
Astellas Pharma China, Inc.

Terminated

A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia

Candidemia | Candidiasis

China
Astellas Pharma Inc

Completed

Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia

Candidiasis

United States, Canada
Pfizer

Completed

Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis

Candidiasis

United States, Korea, Republic of
Pfizer

Completed

An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia

Candidemia

Germany, United States, Israel, Spain, Belgium
Scynexis, Inc.

Completed

Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES) (CARES)

Candidemia | Candidiasis, Invasive

Pakistan, India, United States, South Africa
Hospices Civils de Lyon

Completed

Echinocandins Versus Azoles for Candidemia Treatment (AntiCandiTreat)

Candidemia

France
Giovanni Di Perri
Merck Sharp & Dohme LLC

Completed

Early- and Late-onset Candidemia

Candidemia

Italy
T2 Biosystems

Completed

Detecting Infections Rapidly and Easily for Candidemia Trial - Part 2 (direcT2 Study) (direcT2)

Candidemia

United States
Hacettepe University

Completed

Candidemia in a Pediatric Center and Importance of Central Venous Catheter Removal

Candidemia

Turkey
Gary E. Stein, Pharm.D.
Astellas Pharma US, Inc.

Completed

Comparison of Candida Eradication and Serum Cidal Activity of Echinocandins

Candidemia

United States
Radboud University Medical Center
BioMérieux

Unknown

Efficacy of Interferon-gamma in Combination With Anidulafungin for the Treatment of Candidemia

Candidemia

Netherlands
China Medical University Hospital

Unknown

Risk Factor and Outcome of Candidemia

Candidemia
Pfizer

Completed

Anidulafungin In Treatment Of Candidemia In Asian Subjects

Candidemia

Taiwan, India, Thailand, Philippines
HelixBind, Inc.

Unknown

Assessment of Assay for Rapid Identification of Bloodstream Infections From Whole Blood

Candidemia | Bacteremia

United States
Universitaire Ziekenhuizen KU Leuven

Withdrawn

Bio-assay Development and Implementation for Fungal Infection Detection

Candidemia
Arkansas Children's Hospital Research Institute
Children's Hospital of Philadelphia; St. Jude Children's Research Hospital; George... and other collaborators

Recruiting

Comparison of Uncomplicated Candidemia Therapy Duration in Children (COUNT)

Invasive Candidiasis

United States
Pfizer

Not yet recruiting

A Study to Learn About the Study Medicine (Called Fosmanogepix/ PF-07842805) in People With Candidemia and/or Invasive Candidiasis.

Candidemia | Candidiasis, Invasive
Pfizer

Completed

Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis

Candidemia

United States, Taiwan, Spain, United Kingdom, Korea, Republic of, Brazil, Greece, Canada, Italy, Russian Federation
Astellas Pharma Inc

Completed

Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis

Candidiasis

United Kingdom, Austria, France, Germany, Italy, Poland, Spain, Sweden
Pfizer

Terminated

Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins

Candidemia | Invasive Candidiasis
Pfizer

Terminated

A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis

Candidemia

China
Pfizer

Completed

Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study (ICE)

Invasive Candidiasis

Czech Republic, Belgium, Austria, Portugal, Russian Federation, Turkey, Canada, Germany, Italy, United Kingdom, Hungary, France, Slovakia, Denmark, Romania, Netherlands, Poland, Greece, Ukraine
Pfizer

Completed

This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis

Candidemia | Invasive Candidiasis

Panama, Brazil, Mexico, Chile, Colombia
Gilead Sciences

Completed

CRITIC - Treatment of Candidemia and Invasive Candidiasis (CRITIC)

Candidemia | Invasive Candidiasis

Italy
Cidara Therapeutics Inc.

Completed

CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension (STRIVE)

Mycoses | Candidemia | Fungemia | Fungal Infection | Invasive Candidiasis

United States, Spain, Belgium, Russian Federation, Greece, Bulgaria, Canada, Hungary, Italy, Romania
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Research of New Serological Markers for the Diagnosis and Monitoring of Candidaemia in Hospitalized Patients (2419)

Candida Infection

Italy
Merck Sharp & Dohme LLC
Federal University of São Paulo

Completed

A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093)

Candidemia
Pfizer

Completed

An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris (APEX)

Candidemia | Candida Infection | Invasive Candidiases

South Africa
Pfizer

Completed

Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection

Candidemia | Candidiasis

United States
National Cancer Institute (NCI)

Completed

Anidulafungin Versus Fluconazole in the Treatment of Candidemia

Candidiasis | Candida

United States
University of Houston
Merck Sharp & Dohme LLC

Completed

Clinical Outcomes in Candidemia Patients Based on in Vitro Susceptibility

Candida | Blood Stream Infections
Scynexis, Inc.

Suspended

A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole (MARIO)

Candidemia | Candidiasis, Invasive

United States, Korea, Republic of, Greece, Canada, France, Belgium, Germany, Italy, Spain, South Africa, Bulgaria, Israel
Astellas Pharma Inc
Basilea Pharmaceutica

Completed

Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections

Mycoses | Candidemia | Candidiasis, Invasive

Philippines, New Zealand, United States, Spain, Belgium, Canada, Israel, Malaysia, Mexico, Italy, Australia, Germany, Singapore, Hungary, Brazil, Thailand, China, India, Argentina, France, Russian Federation, Chile, Lebanon, South Africa and more
Astellas Pharma Inc

Completed

Study of Micafungin in Patients With Invasive Candidiasis or Candidemia

Candidemia | Candidiasis

Belgium, France, Germany, Spain, United States, India, Canada, Brazil, Switzerland, Austria, Croatia, Netherlands, Poland, Czech Republic, United Kingdom
Amsterdam UMC, location VUmc
Radboud University Medical Center

Unknown

Anidulafungin Pharmacokinetics in Intensive Care Unit Patients (ANICK)

Candidemia | Invasive Candidiasis

Netherlands

Clinical Trials on Candidaemia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations